Polivy
Brand Name: Polivy
Generic Name: Polatuzumab vedotin
Active
Registration Number
BR-1396
Dosage Form
Powder for Concentrate for Solution for Infusion (IV)
Issuance Date
April 1, 2022
Expiry Date
April 1, 2027
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength140 mg
PackagingSingle dose. 20 mL USP/Ph. Eur./JP Type I borosilicate glass vial with rubber stopper, aluminum seal and blue plastic flip-off cap (Box of l's)
Classification
C
Classification
Prescription Drug (Rx)
A
Application
Monitored Release
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Polatuzumab vedotinActive
Monograph: Polatuzumab vedotin